盐酸海地芬-壳聚糖微球的制备及其释药性能

以戊二醛作为交联剂,盐酸海地芬(CH)为模型药物,通过乳化-化学交联法制备了盐酸海地芬-壳聚糖微球,考察了其理化性质和释药性能。实验结果表明:盐酸海地芬-壳聚糖微球的外表规整,表面光滑,平均粒径7.8μm,载药量为3.4%,药物包封率为58%。该微球在酸性溶液中的释药速率要大于在碱性溶液中,且随壳聚糖(CS)浓度增大而减慢,随交联剂用量的增加而降低。     

金雀异黄素∕壳聚糖微球的制备及其释药性能

制备了金雀异黄素/壳聚糖微球,考察了其理化性质和药物的缓释性能．结果表明,所得微球形状较规整,平均粒径2～4μm,载药质量分数为10.5%,药物包封率达质量分数52.5%．金雀异黄素以无定形聚集态分散在微球内部．微球中的药物有较好的缓释效果,而释药速率随投料比（药物/壳聚糖）的增大而增大,随反应介质pH的增大而增大．药物在酸性缓冲环境中的释药速率大于碱性缓冲环境中的释药速率．     

那格列奈壳聚糖微球的制备及其释放性能

采用乳化分散-化学交联法,以那格列奈(nateglinide)为模型药物,戊二醛为交联剂,制备了那格列奈壳聚糖微球,考察各种条件对所制备微球的理化性质和药物释放性能的影响.结果表明,所得微球球形规整,粒度分布均匀,呈黄褐色,平均粒径2.054 m,载药量为9.12%,药物包封率达48.9%.XRD分析结果表明,微球内部药物主要以无定形聚集态存在.体外模拟释放结果表明,微球有良好的平稳缓释性能.其释药速率随着壳聚糖浓度增大而减慢,在酸性介质中略大于在弱碱性介质中.     

海藻酸钠/壳聚糖缓释微球的制备及性能

利用海藻酸钠(SA)聚阴离子及壳聚糖(CS)聚阳离子电解质的性质,以顺铂(DDP)为模型药,采用乳化交联法制备海藻酸钠-DDP缓释微球,根据静电吸附原理合成SA/DDP/CS复合载药微球.研究微球对药物分子的包载能力及释药特性.结果显示,制备的微球圆整,载药微球表面致密且分散性好,微球粒径在11.0～58.8μm之间,采用原子吸收分光光度计对载药微球的载药率、药物包封率和药物体外释放性质进行了测试和分析,结果表明载药微球缓释效果明显,减少了药物的投放量和投放次数,降低了毒副作用.     

盐酸阿米替林壳聚糖微球的制备及其载药性能

以一种三环类抗抑郁药盐酸阿米替林为模型药物,采用乳化分散-化学交联法,以乙二醇二缩水甘油醚(ethylene glycol diglycidyl ether,EGDE)为交联剂,制备了盐酸阿米替林壳聚糖微球,考察了其理化性质和释放性能.EGDE 两末端为环氧基团,与氨基反应生成-C-N-键从而起交联作用.所得微球球形规整,呈乳白色,释药速率随CS浓度增大而减慢,在酸性缓冲溶液中略大于碱性缓冲溶液中. 研究结果表明盐酸阿米替林-壳聚糖微球具有较好的药物缓释性能.     

盐酸阿米替林/壳聚糖微球的制备

以一种三环类抗抑郁药盐酸阿米替林为模型药物,采用乳化分散-化学交联法,以乙二醇二缩水甘油醚(ethylene glycol diglycidyl ether,EGDE)为交联剂,制备了盐酸阿米替林壳聚糖微球,考察了其理化性质和释放性能.EGDE 两末端为环氧基团,与氨基反应生成－C－N－键从而起交联作用.所得微球球形规整,呈乳白色,释药速率随CS浓度增大而减慢,在酸性缓冲溶液中略大于碱性缓冲溶液中. 结果表明盐酸阿米替林-壳聚糖微球具有较好的药物缓释性能.     

壳聚糖/海藻酸钠水凝胶的制备及其在药物控释中的应用

以戊二醛(GA)为交联剂,壳聚糖作为聚阳离子组分,海藻酸钠作为聚阴离子组分,制备了壳聚糖(CS)海藻酸钠(SA)水凝胶。探讨了改变溶液的pH值和交联剂用量等条件对两种水凝胶溶胀性能的影响。交联剂含量、pH对CS-SA水凝胶溶胀率的影响较大,且在酸性条件下的水凝胶的溶胀率远大于碱性条件下的溶胀率,包埋在此水凝胶中的牛血清蛋白(BSA)释放随载药介质的pH值的变化而显著不同,pH值为1.0条件下载药的水凝胶释药率大于pH值为7.4,9.18条件下的释药率。     

壳聚糖-5-氟尿嘧啶微球的制备

为了制备靶向型药物载体系统,采用超声乳化技术,以5-氟尿嘧啶(5-Fu)为模型药物,液体石蜡为有机分散介质,Span 80为乳化剂,戊二醛为交联剂,对壳聚糖(CS)进行乳化交联,制备了壳聚糖-5-氟尿嘧啶(CS-5-Fu)微球.对超声频率为40 kHz时的制备条件进行了优化,优化条件为:戊二醛用量2 mL,CS浓度1.0%,5-Fu浓度1.0%.采用红外光谱和扫描电子显微镜等对该条件下所得产物的结构和形貌进行了表征,采用紫外-可见光谱对其药物释放性能进行了研究.研究结果表明,CS-5-Fu微球外形为比较规整的球形,粒径在1~4μm之间,分布均匀,包封率为46.7%.在pH=7.2的磷酸盐缓冲溶液中,CS-5-Fu微球在30 h内的累积释药率为60.4%,具有明显的缓释作用.     

诺氟沙星-壳聚糖微球的制备及释药性能

利用乳液一化学交联法,用水溶性壳聚糖（CS）与诺氟沙星（NFX）制备诺氟沙星-壳聚糖微球（NFX-CSM）。根据正交实验设计,考察投料比、交联剂用量、转速和反应温度对质量指标的影响,选出最佳制备工艺条件;利用扫描电镜,红外光谱和Zeta电位仪对载药微球进行表征;用药物溶出度仪检测NFX-CSM在不同pH值环境下的释药速率,并考察不同交联剂用量和投料比（m（CS）：m（NFX））所制备的载药微球对释药速率的影响;将大肠杆菌与NFX-CSM共培养,检测载药微球的抗菌效果。研究结果表明：在最佳制备工艺条件下,制得载药微球的平均粒径约为40m,球形圆整,分散性好,载药量和包封率分别为4．9％和42．3％;载药微球在不同pH值环境下均对药物有良好的缓释效果,其释药速率随交联剂用量的增加和投料比的增大而变小;NFX在CSM的协同抗菌作用下,抗菌效果明显增强。     

蚯蚓纤溶酶壳聚糖微球的制备及性质

以蚯蚓纤溶酶为生物大分子模式药物,研究壳聚糖载药微球的制备方法及对药物活性和稳定性 的影响.以壳聚糖为原料,采用超声乳化交联法制备壳聚糖微球,分别吸附和包埋蚯蚓纤溶酶.在油水体积比 15/1,搅拌转速800 r/min,1 mL戊二醛作为交联剂,超声处理5 min条件下乳化交联制备微球,包埋法具有 较高的栽药率和...     

Dielectric monitoring method for the drug release mechanism of drug-loading chitosan microspheres

The chitosan microspheres loaded with model drug, salicylate molecular, are prepared, and the dielectric spectroscopy of this kind of suspension is measured, meanwhile a significant relaxation is observed for the microspheres suspension. By the modeling analytic of the relaxation, the parameters, which can reflect the properties of microspheres and continuous medium, are obtained. Furthermore, the releasing process of microspheres in aqueous phase is monitored real-timely, namely, by analyzing the time-depe...     

In Vitro Cytotoxicity and Protein Drug Release Properties of Chitosan/Heparin Microspheres

Chitosan/heparin microspheres were prepared using the water-in-oil emulsification solvent evapo- ration technique. The microsphere diameters were controlled by selecting the fabrication process parame- ters. Scanning electron micrographs showed that the chitosan/heparin microspheres were regular and the surface morphology was smooth. Fourier transform infrared showed that the chitosan amino groups reacted with heparin carboxylic groups to form acylamides in the microspheres. Analysis of the microsphere cytotox- icity showed that they had no cytotoxic effect and behaved very similar to the negative control (polystyrene). To analyze the protein drug release profiles of the microspheres, bovine serum albumin was loaded as a model drug into the microspheres and released in vitro. Marked retardation was observed in the BSA re- lease profiles. The results show that chitosan/heparin microspheres may provide a useful controlled release protein drug system for used in pharmaceutics.     

载羟基喜树碱叶酸-壳聚糖微球制备及其缓释性

以羟基喜树碱为药物模型,壳聚糖为药物载体,叶酸为肿瘤靶向配体,利用静电相互作用的原理,通过离子交联法合成载羟基喜树碱的叶酸-壳聚糖(FA-CTS/HCPT)微球.利用动态光散射、扫描电镜、以及红外等技术对微球的结构、平均粒径及粒径分布、形态特征、对药物的包封率及载药量、体外释放等特点进行了初步研究.结果表明,所制得的微球平均粒径为32.65μm.扫描电镜下观察其形态圆整,大小均匀,无粘连.对羟基喜树碱包封率最高为90.9%,载药量为20.9%.在人工胃液pH值1.2及人工小肠液pH值6.8条件下具有很好的缓释作用且无突释现象.     

有序壳聚糖膜的制备及降解性能研究

 以三聚磷酸钠(TPP)作交联剂,用2次交联法,制备了一种新的有序壳聚糖交联膜(CS/TPP),并用溶菌酶对其进行了体外降解性研究,同时用隧道扫描电镜(SPM)对膜进行了表征.结果表明:有序CS/TPP膜有着致密有序的结构和良好的生物可降解性.     

壳聚糖改性微球的微波制备及其吸附性能-1

采用微波辐射法制备了戊二醛交联壳聚糖水杨醛希夫碱微球吸附剂,使用红外光谱和热重分析表征了吸附剂的结构,研究了其对金属离子的吸附性能,同时与采用常规水浴加热制备的微球吸附剂进行了比较.结果表明,微波辐射法能加快反应的进行,制得的吸附剂微球较为均匀,同时增大了对Pb2+、Cd2+的吸附量.     

Preparation and characterization of a chitosan-based low-pH-sensitive intelligent corrosion inhibitor

A chitosan (CS)-based low-pH-sensitive intelligent corrosion inhibitor was prepared by loading a pH-sensitive hydrogel with benzotriazole (BTA); the pH-sensitive hydrogel was synthetized by crosslinking CS with glutaraldehyde (GTA). Analysis by Fourier- transform infrared (FT–IR) spectroscopy showed that Schiff reactions occurred between amino and aldehyde groups. The swelling ability of the hydrogel was investigated using a mass method, and it was observed to swell more in an acidic environment than in an alkaline environment. The hydrogel’s loading capacity of BTA was approximately 0.377 g·g-1, and its release speed was faster in an acidic environment than in an alkaline environment because of its swelling behavior. The corrosion inhibition ability of the intelligent inhibitor was tested by immersion and electrochemical methods. The results showed that after 4 h of immersion, the polarization resistance (R4) value of copper with the intelligent inhibitor was approximately twice of that of copper with BTA, indicating that the intelligent inhibitor could effectively prevent copper from corroding.